Related Experiment Video
Updated: Jul 19, 2026
11:12
Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
Published on: July 16, 2014
Bad oscillations in Parkinson's disease
1Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology, London, United Kingdom. p.brown@ion.ucl.ac.uk
Journal of Neural Transmission. Supplementum
|October 5, 2006
Summary
Synchronized brain activity in the beta band (13-30 Hz) in the basal ganglia is linked to movement control in Parkinson's disease (PD). This oscillatory activity, suppressed by medication and movement, is hypothesized to be antikinetic and relevant to bradykinesia.
Area of Science:
- Neuroscience
- Movement Disorders
- Computational Neuroscience
Background:
- Basal ganglia neurons exhibit synchronized oscillatory activity, observable as local field potentials.
- Synchronized beta band oscillations (13-30 Hz) are prevalent across the basal ganglia-cortical loop in Parkinson's disease (PD).
Purpose of the Study:
- To investigate the role of synchronized beta band oscillations in the basal ganglia.
- To explore the relationship between this oscillatory activity and motor control in PD.
Main Methods:
- Analysis of neural recordings from functional neurosurgery in human patients.
- Observation of local field potentials and neuronal activity within the basal ganglia.
Main Results:
- Basal ganglia neurons show a tendency to oscillate and synchronize, creating rhythmic population activity.
- Synchronized beta band oscillations are a key feature observed in PD patients.
- Dopaminergic medication and physical movement effectively suppress this beta band activity.
- The degree and timing of suppression correlate with behavioral performance.
Conclusions:
- Beta band synchronization in the basal ganglia is hypothesized to be antikinetic.
- This oscillatory activity is considered pathophysiologically relevant to bradykinesia in Parkinson's disease.
Related Concept Videos
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:11Alterations in Muscle Tone lll
Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...
01:37Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.